title: Letter in response to "MDMA-induced angioedema treated with icatibant".
authors.affiliation: a Department of Emergency Medicine , University of Maryland School of Medicine , Baltimore , MD , USA.
authors.forename: R Gentry
authors.initials: RG
authors.lastname: Wilkerson
authors.affiliation: a Department of Emergency Medicine , University of Maryland School of Medicine , Baltimore , MD , USA.
authors.forename: Bryan D
authors.initials: BD
authors.lastname: Hayes
mesh_terms: D000799:Angioedema / Q000139:chemically induced* / Q000188:drug therapy*; D001920:Bradykinin / Q000031:analogs & derivatives*; D065094:Bradykinin B2 Receptor Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000633:toxicity*
chemical_list: D065094:Bradykinin B2 Receptor Antagonists; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D001920:Bradykinin